Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Molecules ; 19(11): 18721-32, 2014 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-25405289

RESUMEN

Many red algae-derived natural products are known to have anticancer effects. The biological functions of the red alga Solieria robusta from the Karachi coast (Pakistan) remain unclear. Here, we prepared a methanolic extracts of S. robusta (MESR) to examine its possible anti-oral cancer effects and the corresponding mechanism of action. Cell viability of MESR-incubated oral cancer Ca9-22 cells was dose-responsively decreased (p<0.001). According to a propidium iodide (PI)-based assay the cell cycle distribution was dramatically changed, especially for subG1 accumulation. Annexin V/PI assay of apoptosis using flow cytometry also showed that MESR-incubated Ca9-22 cells were dose-responsively increased (p<0.001). For evaluation of oxidative stress in MESR-incubated Ca9-22 cells, we found that reactive oxygen species (ROS) were overexpressed dose- and time-responsively and mitochondrial depolarization was also increased (p<0.001). Taken together, MESR showed inhibitory effects on oral cancer proliferation coupled with apoptosis and oxidative stress.


Asunto(s)
Antineoplásicos Fitogénicos , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Neoplasias Gingivales/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales , Rhodophyta/química , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Neoplasias Gingivales/metabolismo , Neoplasias Gingivales/patología , Humanos , Metanol/química , Extractos Vegetales/química , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo
2.
Pan Afr Med J ; 12: 105, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23133705

RESUMEN

Congenital granular cell epulis (CGCE) is a very rare benign soft tissue lesion of the neonate, it most frequently located on the anterior maxillary alveolar ridge. It has a female predilection. It is a tumor with no tendency to recur after excision. The exact histogenesis of this tumor remains unresolved and it may be hamartomata.


Asunto(s)
Anestesia Local/métodos , Neoplasias Gingivales/patología , Tumor de Células Granulares/patología , Femenino , Neoplasias Gingivales/congénito , Neoplasias Gingivales/cirugía , Tumor de Células Granulares/congénito , Tumor de Células Granulares/cirugía , Humanos , Recién Nacido
3.
Gan To Kagaku Ryoho ; 34(4): 597-600, 2007 Apr.
Artículo en Japonés | MEDLINE | ID: mdl-17431347

RESUMEN

We report a successful case with pulmonary metastases from lower gingival cancer by a surgical procedure and four cycles of adjuvant chemotherapy including paclitaxel (PTX), cisplatin (CDDP) and 5-fluorouracil (5-FU). A 47-year-old woman underwent chemotherapy with CDDP and 5-FU after an operation for lower gingival squamous cell carcinoma and its neck lymph node metastases. At 4 months from the initial treatment, pulmonary metastatic lesion was resected by video-assisted thoracoscopic surgery (VATS). Fourteen months later, pulmonary metastatic lesion was found and dissected again using VATS. Furthermore, the patient was treated by adjuvant chemotherapy with PTX 135 mg/m(2) over 3 hours on day 1, CDDP 75 mg/m(2)on day 2 and 5-FU 350 mg/m(2)/day by continuous intravenous infusion on day 2 through 5. After that, there is no evidence of pulmonary recurrence for more than six years.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Escamosas/tratamiento farmacológico , Neoplasias Gingivales/tratamiento farmacológico , Neoplasias Pulmonares/secundario , Ganglios Linfáticos/patología , Neumonectomía/métodos , Carcinoma de Células Escamosas/secundario , Carcinoma de Células Escamosas/cirugía , Quimioterapia Adyuvante , Cisplatino/administración & dosificación , Terapia Combinada , Esquema de Medicación , Femenino , Fluorouracilo/administración & dosificación , Neoplasias Gingivales/patología , Neoplasias Gingivales/cirugía , Humanos , Neoplasias Pulmonares/cirugía , Metástasis Linfática , Persona de Mediana Edad , Paclitaxel/administración & dosificación , Inducción de Remisión , Cirugía Torácica Asistida por Video
4.
Anticancer Res ; 23(2B): 1533-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12820420

RESUMEN

Induction of apoptosis by green tea polyphenols has been observed in various tumor cell systems, but whether green tea polyphenol-induced apoptosis requires caspase 3 for execution has not been confirmed. We previously reported that green tea polyphenol-induced apoptosis involved Apaf-1 accumulation and caspase 3 activation in the cytosol. In the current study, tumor cells either with deleted caspase 3 gene or expressing wild-type caspase 3 were treated with increasing concentrations of green tea polyphenol(s), followed by morphological analysis and caspase 3 activity assay. The caspase 3 null parental cell line was further examined in comparison with a well-characterized, caspase 3 wild type oral carcinoma cell line by MTT assay and BrdU incorporation assay. The results demonstrated that, while the mitochondrial function gradually declined to insignificant levels, caspase 3 null cells did not undergo apoptosis, which suggested that green tea polyphenol-induced apoptosis is a mitochondria-targeted, caspase 3-executed mechanism.


Asunto(s)
Apoptosis/efectos de los fármacos , Caspasas/fisiología , Catequina/análogos & derivados , Flavonoides , Mitocondrias/efectos de los fármacos , Proteínas de Neoplasias/fisiología , Fenoles/farmacología , Extractos Vegetales/farmacología , Polímeros/farmacología , Té/química , Adenocarcinoma/enzimología , Adenocarcinoma/patología , Factor Apoptótico 1 Activador de Proteasas , Neoplasias Óseas/enzimología , Neoplasias Óseas/patología , Neoplasias de la Mama/enzimología , Neoplasias de la Mama/patología , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/secundario , Caspasa 3 , Caspasas/deficiencia , Caspasas/genética , Catequina/farmacología , Replicación del ADN/efectos de los fármacos , Femenino , Eliminación de Gen , Neoplasias Gingivales/patología , Humanos , Queratinocitos/citología , Metástasis Linfática , Neoplasias de la Boca/patología , Proteínas de Neoplasias/deficiencia , Proteínas de Neoplasias/genética , Osteosarcoma/enzimología , Osteosarcoma/patología , Proteínas/metabolismo , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/enzimología , Células Tumorales Cultivadas/patología
5.
Prostaglandins Other Lipid Mediat ; 67(3-4): 181-95, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12013526

RESUMEN

The objective of this study was to find out whether prostaglandin endoperoxide synthase (PHS) involves the action of betel nut extract (BNE) on the growth of oral cancers. Therefore, growth and PHS activity were examined in two human oral carcinoma cell lines (OEC-M1 and KB) and one normal fibroblast cell line (NF) in the presence of increasing BNE concentration. BNE at concentrations above 50 microg/ml significantly inhibited the cell growth of OEC-M1 after 72 h in culture, of KB and NF after 48 h in culture. The IC50 of BNE in OEC-M1, KB and NF at 24 h in culture was about 406, 37.5 and 140 microg/ml respectively. PHS activity in OEC-M1 was significantly increased by low BNE concentrations (50 microg/ml, 114%; 100 microg/ml, 33%; 150 microg/ml, 30%) but significantly reduced at higher BNE concentrations (300 microg/ml, 33%; 500 microg/ml, 61%). The PHS activity in KB was significantly inhibited by BNE and this effect was intensified as concentrations increased (50 microg/ml, 31%; 100 microg/ml, 24%; 150 microg/ml, 43%; 300 microg/ml, 60%; 500 microg/ml, 92%). Similar to that in OEC-M1, the PHS activity in NF was significantly increased at low BNE concentrations (50 microg/ml, 139%; 100 microg/ml, 87%;150 microg/ml, 77%) but reduced at higher concentrations (300 microg/ml, 55%; 500 microg/ml, 72%). The PHS activity in all cell lines was almost completely blocked by indomethacin (5 x 10(-6) M). We conclude that these findings suggest that PHS may be an important biochemical mediator of the effect of BNE on the growth of two human oral carcinoma cell lines.


Asunto(s)
Areca/efectos adversos , Carcinoma de Células Escamosas/patología , Neoplasias Gingivales/patología , Prostaglandina-Endoperóxido Sintasas/metabolismo , Ácido Araquidónico/metabolismo , Carcinoma de Células Escamosas/enzimología , Carcinoma de Células Escamosas/metabolismo , División Celular/efectos de los fármacos , Línea Celular , Inhibidores de la Ciclooxigenasa , Dinoprostona/metabolismo , Relación Dosis-Respuesta a Droga , Eicosanoides/biosíntesis , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Neoplasias Gingivales/enzimología , Neoplasias Gingivales/metabolismo , Humanos , Indometacina/farmacología , Concentración 50 Inhibidora , Células KB , Extractos Vegetales/efectos adversos
6.
Artículo en Es | IBECS | ID: ibc-11233

RESUMEN

El granuloma periférico de células gigantes, es una lesión exofítica que se sitúa en la zona gingival y en el hueso alveolar, de carácter benigno y etiología no muy bien definida. Representa el 7 por ciento de los tumores benignos de los maxilares. En este trabajo, describimos un caso en una mujer de 13 años de edad, con una lesión de crecimiento rápido, localizada en el maxilar superior y realizamos una revisión bibliográfica, estudiando los aspectos epidemiológicos, clinicopatológicos y los posibles tratamientos de este proceso. (AU)


Asunto(s)
Adolescente , Femenino , Humanos , Granuloma de Células Gigantes/diagnóstico , Neoplasias Gingivales/diagnóstico , Neoplasias Maxilares/diagnóstico , Granuloma de Células Gigantes/patología , Granuloma de Células Gigantes , Diagnóstico Diferencial , Diagnóstico Clínico , Neoplasias Gingivales/patología , Neoplasias Gingivales , Neoplasias Maxilares/patología , Neoplasias Maxilares
7.
Anticancer Res ; 20(1A): 257-64, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10769664

RESUMEN

Metallothionein (MT), has selectively binding affinity for heavy metal ions and over expression of MT has a potential against resistance for CDDP anticancer agents and radiation treatment. The role of MT immunoreactivity of squamous cell carcinoma in oral and pharyngeal regions (n = 28) and in the maxillary sinus region (n = 3) was evaluated for distribution patterns of MT and clinicopathologic behaviors. All the sections were examined in 400x and counted for MT positive cells over 5 fields of tumor growing foci. MT immunoreactivity was expressed in both tumor cell cytoplasm and nuclei, and showed heterogeneous localization in tumor epithelial cells and in the stroma. Immunohistochemical localizations showed mosaic patterns as the highest MT staining tumor cells intermingled with negative or low staining cells in neoplastic foci, and in stromal cells. Histiocytic and fibrocytic cells in both peripheral and interstitial stromas were also not stained homogeneously. In oral and pharyngeal carcinomas (n = 28), MT positive cell index in treated cases (n = 11) was 17.85% and that in non treated tumors (n = 17) was 25.19%. In maxillary sinus carcinomas (n = 3), MT positive index was 4.56% and showed lowers levels as compacted to other SCC sites. Among histological grading in oral and pharyngeal SCCs, MT index of well differentiated SCC (n = 9) was 17.04%, of moderately differentiated SCC (n = 13) 21.92% and poorly differentiated SCC (n = 6) was 31.06%. There is no significant correlation of positive index of metallothionein between treated and untreated samples taken in oral and pharyngeal SCCs.


Asunto(s)
Carcinoma de Células Escamosas/química , Neoplasias de Cabeza y Cuello/química , Metalotioneína/análisis , Proteínas de Neoplasias/análisis , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/química , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carboplatino/administración & dosificación , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/radioterapia , Diferenciación Celular , Quimioterapia Adyuvante , Cisplatino/administración & dosificación , Terapia Combinada , Resistencia a Antineoplásicos , Femenino , Fluorouracilo/administración & dosificación , Neoplasias Gingivales/química , Neoplasias Gingivales/patología , Neoplasias Gingivales/terapia , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/patología , Neoplasias de Cabeza y Cuello/radioterapia , Humanos , Neoplasias Hipofaríngeas/química , Neoplasias Hipofaríngeas/patología , Neoplasias Hipofaríngeas/terapia , Metástasis Linfática , Masculino , Neoplasias del Seno Maxilar/química , Neoplasias del Seno Maxilar/patología , Neoplasias del Seno Maxilar/terapia , Persona de Mediana Edad , Mucosa Bucal/química , Neoplasias de la Lengua/química , Neoplasias de la Lengua/patología , Neoplasias de la Lengua/terapia , Resultado del Tratamiento
8.
J Periodontol ; 61(10): 649-52, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2231232

RESUMEN

Reports of gingival peripheral ameloblastoma are extremely rare and have been sporadic. This paper reports a pertinent case of a 40-year-old woman who for 2 years had a progressively enlarging asymptomatic firm mass in the buccal gingival region of the lower premolars. Cupping of the underlying bone was radiographically demonstrated. The lesion was excised surgically together with extraction of the first premolar, and no evidence of recurrence was seen 5 years later. The clinical, radiological, and histopathological characteristics of gingival peripheral ameloblastoma were analyzed in the 33 previously reported cases. The differential diagnosis and treatment of this case report are discussed.


Asunto(s)
Ameloblastoma , Neoplasias Gingivales , Adulto , Ameloblastoma/patología , Diagnóstico Diferencial , Femenino , Neoplasias Gingivales/patología , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA